Clinical Characteristics of Patients with Medically Unexplained Chronic Widespread Pain: A Primary Care Center Study by Lee, Kye Hwa et al.
 doi:10.4082/kjfm.2011.32.5.277 Korean J Fam Med. 2011;32:277-284 
Vol. 32, No. 5 Jul 2011  |  277 Korean J Fam Med
Clinical Characteristics of Patients with 
Medically Unexplained Chronic Widespread 
Pain: A Primary Care Center Study
Original 
Article
Kye Hwa Lee, Cheol Hwan Kim*, Ho Cheol Shin, Eun Ju Sung
Department of Family Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, 
Korea
Background: Chronic widespread pain (CWP) is known as a common symptom of several organic and psychological 
disorders. Although medically unexplained CWP (MUE) has lots of clinical distress symptoms, there were no distinct 
symptoms or signs. Therefore, we conducted this study to investigate clinical distress symptoms of MUE distinct from 
those of medically explained CWP (ME). 
Methods: One hundred nine patients with CWP were enrolled in the study. We classified the study subjects into three 
groups depending on their medical problems associated with CWP: organic group (ORG), psychological group (PSY), 
and MUE. All subjects were asked to ﬁ  ll out self-report questionnaires consisting of clinical distress scales including the 
Korean version of the Fibromyalgia Impact Questionnaire (FIQ-K), fatigue scale, depression scale, and stress scale. And 
physicians examined 18 tender points over their entire body of the subjects. 
Results: MUE patients had higher FIQ-K and fatigue severity scores than ORG patients (all P < 0.05). The average number 
of tender points were 11.33 in MUE patients, 6.48 in ORG patients and 5.02 in PSY patients and statistically signiﬁ  cant (P 
< 0.0001). There were no statistically different factors between MUE and PSY patients with exception for the number of 
tender points. Depressive symptom was the highest in PSY patients but not statistically different from MUE patients. 
Conclusion: MUE patients had higher physical impairments, fatigue severity and more number of tender points than ORG 
patients, but had no different clinical characteristics from PSY patients except for the number of tender points. 
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INTRODUCTION
Chronic widespread pain (CWP) is defined as a pain on 
four quadrants of the body as well as the axial skeleton persisting 
over 3 months. The prevalence of CWP occurs in 10-14% of 
the general population and is more common in women than 
men.
1,2) CWP is a long-lasting condition and worsens patients’ 
quality of life.
3-5) Numerous studies have been performed on 
patients with fibromyalgia syndrome (FMS) and CWP since 
Wolfe et al.
6) suggested a criteria for FMS (American College 
of Rheumatology, ACR) in 1990. CWP has distinct symptoms 
for specific organic and psychological disorders although some 
are medically unexplained in clinical practice.
7) FMS is not a Kye Hwa Lee, et al: Clinical Characteristics of Patients with Medically Unexplained Chronic Widespread Pain
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version of the Beck Depression Inventory (BDI) for measuring 
the severity of depression.
11) BDI had 21 questions asking severity 
of emotional, cognitional and physiological symptoms; responses 
were scored on a 0 to 3 points scale for each item. To evaluate 
the level of stress response, a Stress Response Inventory (SRI) 
was applied to the subjects.
12) SRI had four domains of 39 items 
(emotional, physical, cognitional and behavioral responses of 
subjects) and we measured levels of stress response in subjects by 
summation of the SRI score (score range, 0 to 156). We used the 
FIQ-K for evaluating the impact of CWP on daily living.
13) FIQ-K 
consisted of  a physical function and nine FMS-related symptoms 
(feeling good, sick-leave, impact of fibromyalgia on work, pain, 
fatigue, morning tiredness, stiffness, anxiety, depression during 
the previous week). Physical function consisted of 11 items of 
everyday situations and was assessed by summing the total scores 
on a four point Likert scale for each item. FMS related nine 
symptoms were expressed using a visual analog scale (VAS). 
 
3. Diagnosis of Chronic Widespread Pain 
Patients 
Th   e diagnosis of CWP was done aft  er the patients had met 
the physicians at least 3 times. Physicians noted medical history 
(including psychosocial history) and physical examinations 
thoroughly, and ordered laboratory tests if necessary. Physicians 
concluded whether there was a cause that could explain CWP as 
the final disorder of CWP patients. The diagnosis of CWP was 
based on diagnostic criteria of a specifi  c disease or syndrome and 
also physician’s clinical decision. DSM-IV criteria were applied 
for diagnosing psychological disorders such as depression, panic 
disorder, anxiety, etc. FMS was diagnosed by ACR criteria.
6) 
Th   ose who complained of severe fatigue lasting for more than 6 
months were diagnosed with chronic fatigue syndrome (CFS) or 
idiopathic chronic fatigue (ICF) by the case defi  nition of CDC 
(1988).
14) 
4. Classification of Subjects 
Aft  er major problems associated with CWP were diagnosed 
by physicians, the subjects were classified into two different 
groups. One was the medically explained CWP group (ME) and 
the other was medically unexplained CWP group (MUE). ME 
was then reclassifi  ed into two subgroups, a psychological disorder 
group (PSY) and an organic disorder group (ORG) by their 
specifi  c disease but a syndrome of several medically unexplained 
symptoms such as chronic pain, chronic fatigue, sleep distur-
bances and mood disorders.
8,9) CWP patients are diffi   cult for the 
physician to treat and there are few studies for distinct clinical 
characteristics of medically unexplained CWP. This study was 
designed to investigate the differential clinical characteristics 
between medically unexplained and explained (organic or 
psychological) CWP patients. 
METHODS 
1. Study Participants
Th   is study was conducted in a department of family medicine 
at a university hospital in Seoul, Korea. From April 12 to July 
15 in 2010, patients who agreed to participate in the study were 
interviewed to assess their pain sites and duration by two trained 
nurses. Th   is study protocol was approved by the ethics committ  ee 
of the Kangbuk Samsung Hospital, Sung  kyunkwan University 
School of Medicine (IRB No. KBS10037), and informed consent 
was obtained from each subject. Total 109 CWP patients were 
chosen as the final subjects of this study. CWP was defined as 
follows: pain sites on both sides of the body, above and below 
the waist as well as the axial skeleton of the body, which has 
persisted more than 3 months. Patients who didn’t respond to 
a questionnaire appropriately were excluded. Physicians later 
rechecked the pain sites using a second interview. Further, all 
subjects were asked to fi  ll out a self-report questionnaire. 
2. Questionnaires 
The questionnaire were designed as self-reporting and 
consisted of socio-demographic status, habitual status (smoking 
and alcohol) and clinical distress scales. Socio-demographic 
factors were age, sex, marital status, level of education and current 
occupation. Clinical distress scales were CWP-related symptoms 
such as fatigue severity, depression, level of stress response and 
the Korean version of the Fibromyalgia Impact Questionnaire 
(FIQ-K). The severity of fatigue was assessed by the Korean 
version of the Fatigue Severity Scale (FSS).
10) FSS consisted of 
9 items asking fatigue severity on each diff  erent situation in the 
past 7 days. Each item was scored between 1 to 7 points, and 
summed to a score from 9 to 63 points. We used the Korean Kye Hwa Lee, et al: Clinical Characteristics of Patients with Medically Unexplained Chronic Widespread Pain
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points over the entire body. FIQ-K among three groups were 
analyzed by the score of physical functioning and each score 
of the FMS (nine items) as well as the summation score of the 
FIQ-K (score of the physical functioning plus scores of the nine 
items). For comparison of categorical variables, we used χ
2 analysis 
including non-parametric tests. Continuous variables were 
compared by one-way ANOVA and Tukey’s post hoc test. To 
adjust for confounders, we used ANCOVA for comparing clinical 
distress scales among three groups. A P < 0.05 was defined as 
statistically significant. Statistical analysis was performed using 
SPSS statistics version 18 software (PASW statistics 18, SPSS 
Inc., Chicago, IL, USA).
RESULTS
According to the physicians' diagnosis, 109 CWP patients 
were classifi  ed into 3 groups, 39 for MUE, 25 for ORG and 45 for 
PSY. Table 1 shows the socio-demographic characteristics of each 
group. In the MUE group, ex-smokers were significantly more 
frequent than in the other groups. 
diagnosis. Most MUE patients were diagnosed as FMS, CFS, and 
ICF. If a subject had 2 more disorders for the possible cause of 
CWP and co-morbidities such as FMS and depression, physician 
decided the main cause of CWP clinically.  
5. Statistical Analysis 
We compared the socio-demographic and clinical distress 
scales among three groups (ORG, PSY, MUE). Clinical distress 
scales were FIQ-K, FSS, BDI, SRI, and the number of the tender 
Table 1. Baseline data of the chronic widespread pain subjects (n = 
109).
MUE
 (n = 39) 
ORG




Age (y) 46.3 (14.8) 52.0 (12.7) 50.4 (13.9) 0.221
Female     29 (74.4)     21 (84.0)     32 (71.1) 0.483
BMI 22.7 (2.5) 23.5 (3.7) 22.8 (2.5) 0.558
Smoking status  0.013
   Current smoker      24 (64.9)     19 (79.2)     27 (65.9)
   Ex-smoker      11 (29.7)       1 (4.2)       4 (9.8)
   Non-smoker        2 (5.4)       4 (16.7)     10 (24.4)
Alcohol       0.193
   Less than
     1 time/mo
    27 (96.4)     18 (85.7)     31 (81.6)
   More than
     2-3 times/mo
      1 (3.6)       3 (14.3)       7 (18.4)
Marital status 0.096
   Married      26 (68.4)     21 (87.5)     35 (85.4)
   Unmarried      12 (31.6)       3 (12.5)       6 (14.6)
Education 0.077
   High school 
     graduated or less 
    14 (36.8)     12 (50.0)     25 (62.5)
   College graduated 
      or more 
    24 (63.2)     12 (50.0)     15 (37.5)
Occupation 0.438
   Full time job     20 (52.6)     15 (60.0)     19 (44.2)
   Others     18 (47.4)     10 (40.0)     24 (55.8)
Values are presented as mean (SD) or number (%).
P-value < 0.05 indicates a statistically signiﬁ  cant difference.  
MUE: medically unexplained, ORG: organic problem associated 
with CWP , PSY: psychological problems associated with CWP , CWP: 
chronic widespread pain, BMI: body mass index, SD: standard 
deviation. 
Table 2. Major problems associated with chronic widespread pain 
patients (n = 109).
MUE 
(n = 39)    
No.
ORG 
(n = 25)          
No.
PSY
(n = 45)    
No.
FMS 24 Rheumatoid arthritis 10 Depression 23
CFS             10 Osteoarthritis   6 Stress/overwork   6
 ICF  5 Gout   1 Panic disorder   4
Osteoporosis   1 Somatoform 
   disorder
  4
Thyroid cancer   1 Anxiety disorder   4
Stomach cancer   1 HwaByung   4
Brain tumor   1
Grave’s disease   1 
Hypothyroidism   1
Seizure   1  
Atopic dermatitis   1
MUE: medically unexplained, ORG: organic problem associated 
with CWP , PSY, psychological problem associated with CWP , CWP: 
chronic widespread pain, FMS: fibromyalgia syndrome, CFS: 
chronic fatigue syndrome, ICF: idiopathic chronic fatigue.Kye Hwa Lee, et al: Clinical Characteristics of Patients with Medically Unexplained Chronic Widespread Pain
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Major problems associated with CWP patients were shown 
in Table 2. Th   irty-nine patients of MUE were diagnosed as FMS 
(n = 24, 61.5%), CFS (n = 15, 25.5%), and ICF (n = 5, 12.8%). 
In ORG, rheumatoid arthritis (RA   ; n = 10, 40%) was the most 
common medical problem followed by osteoarthritis (OA; 
n = 6, 24%), other musculoskeletal or metabolic diseases and 
malignancies. In PSY, depression (n = 23, 53%) was the most 
common problem as well as stress and being overworked. Panic, 
anxiety and somatization disorders were also diagnoses for PSY. 
Table 3 showed Clinical Distress Scales among three groups. 
Physical impairment scores were 15.3 ± 7.9 for MUE, 11.3 ± 
8.7 for ORG, and 14.8 ± 8.1 for PSY but there was no diff  erence 
among them (P = 0.145). Th   e numbers of days feeling good in the 
past seven days were signifi  cantly lower for MUE and PSY than 
ORG (P = 0.001). Work missed was not diff  erent among groups. 
Tiredness was signifi  cantly higher in MUE than ORG and anxiety 
scores were higher in PSY than ORG. But, the ability to do work, 
pain, rest, stiffness and depression levels were not significantly 
different among groups. Comparing the FIQ-K scores of each 
group, MUE had a higher score than ORG group (P = 0.003). 
MUE had a higher level of fatigue severity as assessed by FSS than 
PSY and ORG (P = 0.007). BDI score was highest in PSY. MUE 
showed a higher stress score than ORG and more numbers of 
tender points than the other two groups (P < 0.0001). As a result 
of multivariated analysis, MUE group showed signifi  cantly higher 
score in FIQ, FSS, and SRI than ORG group. PSY group showed 
higher score in VAS anxiety scale, FIQ, BDI, and SRI than ORG 
group signifi  cantly. MUE had a higher number of tender points 
than the other two groups aft  er mutlivariated analysis. Otherwise 
the number of days felt good last week was slightly higher in MUE 
Table 3. Clinical distress scales of MUE, ORG, and PSY disorders associated with CWP .
  MUE (n = 39) ORG (n = 25) PSY (n = 45)
P-value
Mean SD Mean SD Mean SD
FIQ-K 
  Physical impairment  15.3  7.9 11.3  8.7 14.8  8.1  0.140
  Feel good     4.1  3.4   6.9*  2.3 5.7  2.8  0.001
  Work missed     1.2  2.4   0.1  0.4 0.7  2.4  0.160
  Do work    6.2   3.1   4.5  3.7 5.7  3.2  0.118
  Pain    6.2  2.9   4.4  3.4 5.4  3.3  0.088
  Fatigue      8.2*  1.8   6.3  3.0 7.2  2.8  0.025
  Rested    7.7  2.4   6.7  2.5 7.0  2.6  0.270
  Stiffness    7.2  2.5   5.6  3.0 5.9  3.2  0.076
  Anxiety     7.3*  2.4   5.3  3.3 7.3
†  2.5  0.007
  Depression    6.8  2.7   5.6  3.2 6.9  2.4  0.116
Sum. of FIQ-K   72.4* 18.1 53.4 22.8 65.3 22.3  0.003
Fatigue severity scale  48.6
‡ 13.4 37.1 17.3 39.3 16.2  0.007
Beck depression inventory 51.4  8.4 46.8  9.1 52.3
†  8.2  0.034
Stress response inventory 103.6* 27.9 74.0 30.4 99.9
† 31.5  <0.0001
NTPs  11.3
‡  5.5   6.5  4.8 5.0  3.9  <0.0001
Data were analyzed by one-way ANOVA followed by Tukey post Hoc test. P-value < 0.05 indicates statistical signiﬁ  cance. 
MUE: medically unexplained, ORG: organic problem associated with CWP , PSY: psychological problem associated with CWP , CWP: chronic 
widespread pain, SD: standard deviation, FIQ-K: Korean version of Fibromyalgia Impact Questionnaire, Sum. of FIQ-K: summation score 
of FIQ-K, NTPs: no. of tender points over the entire body.
*Significant difference between MUE and ORG group. 
†Significant difference between ORG and PSY groups. 
‡Significant difference 
between MUE and ORG, PSY groups.Kye Hwa Lee, et al: Clinical Characteristics of Patients with Medically Unexplained Chronic Widespread Pain
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DISCUSSION
It is known that patients with CWP suff  er more psychological 
illness and oft  en experience more disorders such as CFS, FMS, 
group than other 2 groups. Th   e results were presented in Figure 1.
Figure 1. Psychological distress scales for MUE, ORG, and PSY 
group. Multivariated analysis, adjusted age, sex, BMI, smoking, 
alcohol habits, educaion, marriage, occupation. P-value < 0.05 
indicates statistical significance. MUE: medically unexplanined, 
ORG: organic problem associated with CWP , PSY: psychological 
problem associated with CWP , CWP: chronic widespread pain, VAS: 
visual analog scale, FIQ-K: Korean version of Fibromyalgia Impact 
Questionnaire, FIQ-sum: summation score of FIQ-K. *Means 
statistically signiﬁ  cant difference between two groups. Kye Hwa Lee, et al: Clinical Characteristics of Patients with Medically Unexplained Chronic Widespread Pain
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10% of CWP complaints were due to rheumatoid arthritis and 
degenerative arthritis, respectively.
26)
In our study, ORG of CWP patients was 22.9% (25/109), 
9.2 % (10/109) for RA and 5.5 % for OA (6/109). These low 
percentages of RA    and OA for CWP in our study were thought to 
be due to the diff  erence of study subjects visiting our center and 
further research is needed in Korea for clarifi  cation. 
Our study showed that MUE tended to have poorer physical 
functioning, higher levels of stress response and fatigue severity 
than PSY. FMS had a number of associated symptoms such as 
chronic fatigue, irritable bowel and chronic pelvic pain while 
patients with multiple conditions had a poor quality of life, more 
severe functional disabilities and depressive moods.
27,28) Although 
co-morbidity conditions of MUE were not evaluated in this study, 
they were more likely to have associated psychological diseases 
which give rise to the functional disability and psychological 
symptoms. 
MUE showed more severe depressed moods, higher levels of 
stress response and severe fatigue than the ORG. And functional 
impairment due to pain was more severe in MUE. Th  ese  results 
were consistent with previous studies.
10,29) 
The number of tender points over the entire body was 
signifi  cantly higher in MUE than in ME. Because MUE included 
FMS, the result was not surprising. These results were also 
consistent with previous studies showing that FMS had more 
tender points and also higher distress such as fatigue as well as 
impairment of physical functioning.
18,30) Additionally, Yunus
31) 
suggested a concept of central sensitization (CS) that pain in FMS 
is related to CS and the pathophysiological mechanism of CS is 
associated with activation of peripheral nociceptive C fibers in 
chronic pain by several neurochemicals (substances P, serotonin 
and bradykinin). In practice, CS can be checked by tender points 
on the body indirectly. Th   us, our results that MUE had increased 
numbers of tender points on the body may be consistent with the 
aforementioned hypothesis of CS. 
There are some limitations of our study. First, the major 
problem associated with CWP of subjects was determined by 
only a single disorder. Most of the patients with CWP had several 
diseases and it is diffi   cult to confi  rm whether one or two specifi  c 
diseases or a syndrome were the major cause of CWP.
32) Thus, 
we had a difficulty in differentiating between MUE and PSY 
because most MUE patients had psychological co-morbidities 
depression, and irritable bowel disease than those without 
CWP.
15,16) FMS and CFS are also well known disorders with 
CWP.
17) These syndromes have common complaints including 
severe fatigability, disability, chronic pain and depressive mood 
as well as a tendency to progress to a chronic state.
18) But neither 
biologic indicators nor specifi  c diagnostic criteria exist to explain 
these syndromes.
4) We therefore conducted this study to search 
for diff  erential clinical characteristics of MUE for which diagnoses 
and definitions are unclear between psychological illness and 
organic disorders. 
Our research showed that patients with MUE had a higher 
level of fatigue, physical impairment and number of tender 
points on the body than ME, especially ORG but clinical distress 
symptoms such as severity of depression and level of stress were 
no diff  erent between MUE and PSY. MUE had diff  erential clinical 
distress symptoms from ORG such as rheumatoid arthritis and 
osteoarthritis but similar with PSY. We suggest a few explanations 
for these similarities between MUE and PSY. First, MUE (FMS 
and CFS in our study) is not a single disorder but a spectrum of 
several disorders. Bradley
19) and Hudson et al.
20) had suggested 
that ten types of mental illnesses including major depression, 
generalized anxiety disorder and four kinds of medical conditions 
including FMS, IBS, migraine and cataplexy as referred as 
aff  ective spectrum disorders. Additionally, another study showed 
that lifetime prevalence of major depression in FMS patients was 
significantly higher than in the general population and as with 
depression, FMS is accompanied by similar symptoms including 
various functional disabilities, depressive moods, memory 
impairment, vulnerability to stress and autonomic nervous system 
dysfunction. Th   erefore, both disorders have been claimed to have 
the same underlying mechanism.
21) Second, in patients with CFS 
or FMS, antidepressants can relieve their pain regardless of the 
mood of patients.
22,23) Thus, medically unexplained syndromes 
like FMS and CFS are likely to have a similar disease mechanism 
including depression and somatization disorders. Third, the 
prevalence of depression in patients with FMS or CFS is higher 
than in the general population. In a Finnish study, the prevalence 
of depression was much higher in FMS patients than those 
without FMS (56% vs. 17%).
24) Raphael et el.
25) also reported 
that women with FMS had a 69.8% chance of life-time prevalence 
of depression compared to 34.3% of women with no FMS in 
a community-based study. Lars et al. reported that 20% and Kye Hwa Lee, et al: Clinical Characteristics of Patients with Medically Unexplained Chronic Widespread Pain
Vol. 32, No. 5 Jul 2011  |  283 Korean J Fam Med
such as depression, sleep disturbances etc. However, in our study, 
physicians interviewed the patients more than three times and 
performed CWP-related laboratory tests, if necessary and then 
decided only a major cause explaining CWP. Th   us we think that 
this limitation is not big enough to aff  ect our results but further 
studies will be necessary in the future. Second, the study results 
can’t represent the characteristics of all CWP patients because 
the subjects were patients visiting the department of a university 
hospital. Th   ird, the number of study subjects was relatively small 
so that some clinical characteristics of MUE were unlikely to be 
signifi  cantly diff  erent from ME. 
Despite these limitations, we found MUE had some diffe-
rential clinical distress symptoms from ME, especially ORG and 
our study was the first investigation for clinical characteristics 
of medically unexplained CWP patients in Korea. In the future, 
further studies are needed to determine whether the various 
symptoms presented in patients with medically unexplained 
chronic widespread pain might explain the pathophysiology of 
the pain mechanisms. 
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